Targeting sarcoma tumor-initiating cells through differentiation therapy.

Abstract excerpt

Human leukocyte antigen class I (HLA-I) down-regulation has been reported in many human cancers to be associated with poor clinical outcome. However, its connection to tumor-initiating cells (TICs) remains unknown. In this study, we report that HLA-I is down-regulated in a subpopulation of cells that have high tumor initiating capacity in different types of human sarcomas. Detailed characterization revealed their...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinogenesis
• Share to Cell Differentiation